UK-based Chronomics, Ltd. has launched an ‘industry-first program’ to assist traveller safety and support the ongoing viability of the travel trade through the introduction of commercial partnerships for wholesale and retail partners engaged in the sale of its innovative, UK government-authorized COVID-19 PCR tests for travellers arriving in and departing from the United Kingdom.
Dr. Tom Stubbs, CEO of Chronomics, said that: “In our efforts working with government on opening up travel responsibly, we very quickly realized that the travel trade is an integral part of helping travellers who must travel to do so safely, similarly to the importance of travel insurance in every itinerary.”
Chronomics currently processes thousands of PCR tests every day for clients across Europe and is one of the only providers whose product allows self-administered, at-home/at-hotel, saliva-based testing in the UK government’s official “Test to Release for International Travel” program.
Additionally, Chronomics is the only testing provider offering commercial partnerships to the travel trade on a global basis.
Said Dr. Stubbs: “If a travel wholesaler or retailer is sending clients to or from the UK and they require testing, we want to be their trusted partner as they spend their valuable time and resources helping their clients travel safely.”
Chronomics is also in discussions with similar COVID testing firms in major markets to assist the travel trade in having a network of trusted partners for their clients.
Interested travel wholesalers and retailers are invited to reach out to email@example.com to learn more.
Chronomics, Ltd. was founded in 2017 and is a UK-based biotechnology company founded on the use of epigenetics to give people the knowledge of how their environment and lifestyle is imprinting itself on their DNA and affecting their health.
In response to the COVID-19 pandemic, Chronomics developed a CE-marked, UK government-authorized saliva testing kit trusted by thousands of people per day across Europe to detect the presence of RNA from SARS-CoV-2 (COVID-19 virus).
Go to www.chronomics.com .